Abstract P1-11-20: Patient reported supportive care needs in a dedicated advanced breast cancer center
Geske, SJ, Pluard, TJ, Amazu, C, Holden, R
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Abstract P4-01-05: Cell free DNA analysis identifies actionable ERBB2 amplifications in patients with HER2 equivocal breast cancer
Rich, TA, Raymond, VM, Ahn, ER, Banks, KC, Brufsky, A, Lee, C, Lippman, M, Pluard, TJ, Schwab, RB, Lanman, RB
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Abstract PD1-02: Withdrawn
Cortes, J, Martin, M, Pernas, S, Gomez Pardo, P, Lopez-Tarruella, S, Gil-Martin, M, Manso, L, Ciruelos, E, Perez-Fidalgo, JA, Hernando, C, Ademuyiwa, FO, Weilbaecher, K, Mayer, I, Pluard, TJ, Martinez Garcia, M, Vahdat, L, Wach, A, Barker, D, Romagnoli, B, Kaufman, PA
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Abstract PD1-01: Trilaciclib (T), a CDK4/6 inhibitor, dosed with gemcitabine (G), carboplatin (C) in metastatic triple negative breast cancer (mTNBC) patients: Preliminary phase 2 results
O'Shaughnessy, J, Wright, GS, Thummala, AR, Danso, MA, Popovic, L, Pluard, TJ, Cheung, E, Han, HS, Daniel, BR, Vojnovic, Z, Vasev, N, Ling, M, Richards, DA, Wilks, ST, Milenkovic, D, Sorrentino, JA, Roberts, PJ, Bomar, M, Yang, Z, Antal, JM, Malik, RK, Morris, SR, Tan, A
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Abstract P6-12-15: Efficacy results of a phase 1/2 study of glucocorticoid receptor (GR) antagonist mifepristone (MIFE) in combination with eribulin in GR-positive triple-negative breast cancer (TNBC)
Han, HS, Wilks, S, Paplomata, E, Modiano, MR, Becerra, C, Braiteh, FS, Spira, AI, Pluard, TJ, Richards, DA, Conzen, SD, Baker, G, Fishman, RS, Marcantonio, A, O'Shaughnessy, J, Nanda, R
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Ezh2, a novel target in detection and therapy of breast cancer
Pourakbar, Sarah, Pluard, Timothy J, Accurso, Anthony D, Farassati, Faris
Published in OncoTargets and therapy (01.01.2017)
Published in OncoTargets and therapy (01.01.2017)
Get full text
Journal Article
Abstract S5-01: Impact of the addition of carboplatin (Cb) and/or bevacizumab (B) to neoadjuvant weekly paclitaxel (P) followed by dose-dense AC on pathologic complete response (pCR) rates in triple-negative breast cancer (TNBC): CALGB 40603 (Alliance)
Sikov, WM, Berry, DA, Perou, CM, Singh, B, Cirrincione, C, Tolaney, S, Kuzma, CS, Pluard, TJ, Somlo, G, Port, E, Golshan, M, Bellon, JR, Collyar, D, Hahn, OM, Carey, LA, Hudis, C, Winer, EP
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Get full text
Journal Article